Market Closed

TNGX
Tango Therapeutics
$ 25.50
2.62%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Tango Therapeutics News

Latest Tango Therapeutics Stock News & TNGX Headlines

Tango Therapeutics (NASDAQ:TNGX) Stock Price Breaks Above 50-Day Moving Average After Earnings Miss
4 days ago | defenseworld.net
Tango Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Highlights
6 days ago | globenewswire.com
Tango Therapeutics to Participate in Guggenheim's 3rd Annual Healthcare Innovation Conference
12 days ago | globenewswire.com
Tango Therapeutics: The ESMO Sell-Off Missed What The Daraxonrasib Dose Is Saying
17 days ago | seekingalpha.com
TNGX Stock Falls 16% Despite Positive Pancreatic Cancer Study Data
19 days ago | zacks.com
Tango Therapeutics, Inc. (TNGX) Discusses Updated Vopimetastat Combination Data and Registration Strategy in Pancreatic Cancer Transcript
22 days ago | seekingalpha.com
Tango Therapeutics Targets 2027 Phase III Trial After 82% Pancreatic Cancer Response Rate
23 days ago | marketbeat.com
Why Is Tango Therapeutics Stock Trading Lower After Cancer Drug Data?
23 days ago | benzinga.com
Tango Therapeutics Just Improved On This 'Unprecedented' Cancer Drug
23 days ago | investors.com
Tango Presents Promising Results from Phase 1/2 Study of Vopimetostat and Daraxonrasib in Pancreatic Cancer and Provides Updates to Development Strategy
23 days ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

TNGX
Tango Therapeutics
$ 25.50
2.62%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago